Amino sulfonic acid fact sheet
Taurine
Also known as 2-aminoethanesulfonic acid
Taurine is important in normal physiology and extended lifespan in some animal experiments. Newer human and longitudinal evidence challenges the idea that falling taurine is a universal driver of aging.
Quick answer
Taurine is not an FDA-approved anti-aging treatment. A major animal study sparked longevity interest, but later human and cross-species studies did not confirm circulating taurine as a reliable aging biomarker or deficiency as a universal human aging driver.
By the PeptideFactSheets Editorial Team. Claims are source-checked under our editorial policy; clinician review is identified only when a named reviewer is shown.
What is Taurine?
Taurine is an amino sulfonic acid present in many tissues and involved in bile acids, cell-volume regulation, calcium signaling, and nervous-system and muscle biology.
It is not incorporated into proteins like a standard amino acid, and blood concentration may not directly represent tissue status or treatment need.
Why are people interested in it?
A 2023 Science study reported lower taurine with age in selected data and longer lifespan in treated mice and worms.
Subsequent human cohorts and direct physiology work found stable or increasing levels with age and no consistent link to strength or mitochondrial function.
Current regulatory status
No taurine drug is FDA approved to slow aging, extend lifespan, prevent frailty, or improve general performance. Supplement marketing does not equal FDA-reviewed effectiveness.
What is it approved for?
No FDA-approved use. Commercial availability, supplement marketing, and clinical research do not equal an FDA-approved medicine.
What is it being studied for?
Evidence snapshot
Animal intervention evidence is provocative, while human evidence is observational, inconsistent, and increasingly contradictory. No human longevity trial establishes benefit.
Potential benefits being researched
- Animal experiments reported improved health measures and lifespan in selected species.
- Human associations do not establish benefit, and newer studies directly challenge the claimed age-related deficiency pattern.
A mechanism, biomarker, or secondary endpoint is not proof of a meaningful clinical benefit.
Known or possible risks
- Supplement trials are not large or long enough to define every uncommon harm or interaction.
- A normal or altered blood level does not automatically identify a deficiency that should be corrected.
- Commercial combination products can add ingredients and risks unrelated to taurine itself.
What we still do not know
- Whether taurine improves any validated human aging outcome
- Which tissue measures, if any, reflect a clinically meaningful deficiency
- Whether animal lifespan effects translate to people
- Long-term effects in diverse populations
Plain-English takeaway
Taurine is biologically important, but the simple story that taurine deficiency drives human aging has not held up cleanly. Human longevity benefit is unproven.
Research and reference links
Use these primary and authoritative sources to verify status and read beyond this summary. A study or registry entry does not by itself prove benefit.
- 1Taurine deficiency as a driver of aging
Influential multi-species study with animal intervention and human association components.
- 2Longitudinal challenge to taurine as an aging biomarker
Human and cross-species data finding stable or increasing circulating taurine with age.
- 3Human evidence against taurine deficiency as an aging driver
Human physiology study finding no association with age, strength, performance, or mitochondrial function.
- 4FDA: dietary supplements are not preapproved for effectiveness
FDA explanation of the regulatory distinction between approved drugs and marketed dietary supplements.